Clarus Sets Second Quarter 2024 Conference Call for Thursday, August 1, 2024, at 5:00 p.m. ET
SALT LAKE CITY, July 19, 2024 (GLOBE NEWSWIRE) — Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company […]
NANO Nuclear Energy Closes Full Over-Allotment Option Raising Total Funds of $20 Million in Underwritten Follow-On Offering
New York, N.Y., July 19, 2024 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear”), a vertically integrated microreactor […]
Reliance Global Group Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
Lakewood, NJ, July 19, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (NASDAQ: RELI) (“Reliance” or the “Company”), announced today […]
Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
July 19, 2024 Biodexa Pharmaceuticals PLC Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals […]
Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated […]
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical […]
Sify (NASDAQ: SIFY) reports Consolidated Financial Results for Q1 FY 2024-25
CHENNAI, India, July 19, 2024 (GLOBE NEWSWIRE) — EARNING CALLS DETAILS […]
Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its […]
Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SARASOTA, FL, July 19, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage […]
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that […]
